<DOC>
	<DOCNO>NCT01067781</DOCNO>
	<brief_summary>The purpose study evaluate compare safety immune response follow two vaccination regimen transcutaneous immunization heat-labile enterotoxin E. coli ( LT ) patch placebo</brief_summary>
	<brief_title>Gender-Stratified Safety Immunogenicity Study</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . A female male 1864 ( inclusive ) year age ; 2 . In good health determine medical history screen exam ; 3 . Females postmenopausal , surgically sterile , negative serum/urine pregnancy test Day 0 agree become pregnant duration study . 1 . Abnormalities physical exam [ determine Toxicity Grading Scale ( Grade 14 ) ] ; 2 . Laboratory abnormality [ determine Toxicity Grading Scale ( Grade 1 4 ) ] screening ; 3 . Participated research involve investigational product within 30 day plan date first vaccination ; 4 . Ever receive investigational enterotoxigenic E. coli , LT , LT ( R192G ) NasalFlu , Berna Biotech , Ltd ; 5 . Women pregnant breastfeeding ; 6 . Clinically significant underlying enteric , pulmonary , cardiac renal disease ; 7 . Current seizure disorder ; 8 . Current use immunosuppressive therapy ( inhaled steroid allow ) ; 9 . Known suspected alcohol abuse illicit drug use within last year ; 10 . Positive Serology HIV1 , HIV2 , HbsAg , HCV ; 11 . Known allergy component vaccine include adhesive ; 12 . An employee study site ; 13 . An employee Intercell ( global ) immediate family member ; 14 . Visible tattoos mark ( tattoos/scars ) vaccination area would prevent appropriate dermatologic monitoring vaccination sit ; 15 . Receipt routine vaccination within 7 day prior , follow , date plan study vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Prevention Travelers ' Diarrhea</keyword>
</DOC>